AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 11196760
Drug: Ferrous sulphate
RxNorm normalized name: Ferrous sulphate
DrugBank: Ferrous fumarate (DB14491)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ferrous sulphate (6 mg/kg/d)
Trial: 6147051
Drug: Oxmetidine 400
RxNorm normalized name: cimetidine 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxmetidine 400 mg
Trial: 6147051
Drug: Oxmetidine 800
RxNorm normalized name: cimetidine 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxmetidine 800 mg
Trial: 6147051
Drug: Oxmetidine (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxmetidine (all doses)
Trial: 6147051
Drug: Oxmetidine (800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxmetidine (800 mg)
Trial: 6147051
Drug: Oxmetidine (highest
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxmetidine (highest dose)
Trial: 6147051
Drug: Oxmetidine (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxmetidine (400 mg)
Trial: 29266965
Drug: Intensified-dose ICS/LABA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensified-dose ICS/LABA
Trial: 26440923
Drug: 0.5 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 μg vitamin D3 per day
Trial: 26591679
Drug: Acupuncture-Medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture-Medicine
Trial: 10356137
Drug: Dexamethasone (DXM)
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Dexamethasone (DXM) 0.25 mg/kg
Trial: 8619455
Drug: Meglumine ioxitalamate
RxNorm normalized name: meglumine ioxithalamate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meglumine ioxitalamate (100 mL via nasogastric tube)
Trial: 8619455
Drug: Standard conservative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard conservative treatment without contrast material
Trial: 6094458
Drug: Cefotaxime 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefotaxime 0.5 g single dose
Trial: 6094458
Drug: Cefotaxime 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefotaxime 0.5 g twice a day for 10 days
Trial: 6094458
Drug: Cefotaxime 1
RxNorm normalized name: cefotaxime 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefotaxime 1 g twice or three times a day for 10 days
Trial: 31800488
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg mecamylamine
Trial: 29651664
Drug: Neoadjuvant chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant chemotherapy + surgery
Trial: 29651664
Drug: Surgery +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgery + adjuvant chemotherapy
Trial: 29651664
Drug: Any chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Any chemotherapy with surgery
Trial: 19380753
Drug: Daily enteral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily enteral supplementation with zinc, selenium, and glutamine plus parenteral metoclopramide
Trial: 11423056
Drug: 5-mg warfarin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-mg warfarin group
Trial: 11423056
Drug: 2.5-mg warfarin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5-mg warfarin group
Trial: 9421775
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of cefuroxime (3 g or 1.5 g)
Trial: 9421775
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of vancomycin (1.5 g)
Trial: 9421775
Drug: Additional dose
RxNorm normalized name: chromous chloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Additional dose during cardiopulmonary bypass of cefuroxime
Trial: 9421775
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of cefuroxime
Trial: 9421775
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of vancomycin
Trial: 8335738
Drug: Topical fluocinolone
RxNorm normalized name: fluocinolone Topical Ointment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical fluocinolone acetonide ointment (0.025%) diluted by area of application
Trial: 8335738
Drug: Topical fluocinolone
RxNorm normalized name: fluocinolone Topical Ointment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical fluocinolone acetonide ointment (0.025%) diluted by volume (1:1 and 1:3)
Trial: 8335738
Drug: In vitro
RxNorm normalized name: glucuronidase in vitro test
FDA approved: no
EMA approved: no
PMDA approved: no
Description: In vitro method measuring fluocinolone release from diluted ointments
Trial: 3117998
Drug: 0.5 g/kg/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 g/kg/d lipid for 5 days (group 1)
Trial: 3117998
Drug: 0.5 g/kg/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 g/kg/d increased to 2.0 g/kg/d over 5 days (group 2)
Trial: 3117998
Drug: Lipid infusion
RxNorm normalized name: guggul lipids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lipid infusion at 0.5 to 2.0 g/kg/d
Trial: 26785406
Drug: HeLP‐her self‐management
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HeLP‐her self‐management lifestyle intervention (1 group session, monthly SMS text messages, 1 phone coaching session, program manual)
Trial: 25197804
Drug: Intravenous acetazolamide
RxNorm normalized name: Acetazolamide
DrugBank: Acetazolamide (DB00819)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous acetazolamide (10 mg/kg)
Trial: 22252827
Drug: Rifampin 450
RxNorm normalized name: rifampin 450 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rifampin 450 mg daily
Trial: 22252827
Drug: Rifampin 600
RxNorm normalized name: rifampin 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rifampin 600 mg daily
Trial: 10063942
Drug: Policosanol 10
RxNorm normalized name: policosanol 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Policosanol 10 mg twice daily
Trial: 7886417
Drug: Intracavernosal papaverine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracavernosal papaverine hydrochloride (8 mg) plus intraurethral capsaicin (10(‐5) M)
Trial: 7886417
Drug: Intracavernosal papaverine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracavernosal papaverine hydrochloride (8 mg) plus intraurethral saline infusion
Trial: 7886417
Drug: Intraurethral saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraurethral saline solution
Trial: 27986972
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D (50,000 IU weekly for 12 weeks)
Trial: 25651782
Drug: Tofacitinib (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tofacitinib (0.5 mg, 3 mg, 10 mg)
Trial: 21903531
Drug: Cetylpyridinium chloride
RxNorm normalized name: Cetylpyridinium Chloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cetylpyridinium chloride in combination with sodium fluoride
Trial: 16310895
Drug: Heparin 1500
RxNorm normalized name: Heparine
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Heparin 1500 units
Trial: 16310895
Drug: Hydrocortisone 15
RxNorm normalized name: hydrocortisone 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrocortisone 15 mg
Trial: 16310895
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of Heparin and Hydrocortisone
Trial: 14600553
Drug: CON (continued
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CON (continued weekly training)
Trial: 1539506
Drug: Thrombolytic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrombolytic therapy (streptokinase)
Trial: 1512330
Drug: Thrombolytic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrombolytic therapy (rt-PA)
Trial: 1539506
Drug: Thrombolytic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrombolytic therapy preceded by acetylsalicylic acid
Trial: 3894707
Drug: Seven-day course
RxNorm normalized name: Sevenfact
DrugBank: Coagulation factor VIIa Recombinant Human (DB00036)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Seven-day course of 500 mg metronidazole given twice daily
Trial: 18084150
Drug: Ongoing prospective
RxNorm normalized name: Ongo-Fin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ongoing prospective randomized studies (Surgical Treatment for Ischemic Heart Disease trial, Heart Failure Revascularization trial, PET and Recovery Following Revascularization-2 trial)
Trial: 16045667
Drug: Infraclavicular block
RxNorm normalized name: Ivy Block
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infraclavicular block (single injection)
Trial: 16045667
Drug: Axillary block
RxNorm normalized name: Ivy Block
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Axillary block (multiple injections)
Trial: 7872274
Drug: Olsalazine (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olsalazine (1 g daily)
Trial: 25282519
Drug: Evolocumab 140
RxNorm normalized name: evolocumab 140 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Evolocumab 140 mg every 2 weeks
Trial: 28081288
Drug: Short implants
RxNorm normalized name: short ragweed pollen extract Sublingual Tablet [Ragwitek]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short implants (6 mm)
Trial: 28081288
Drug: Long implants
RxNorm normalized name: long pepper extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long implants (11‐15 mm)
Trial: 28081288
Drug: Long implants
RxNorm normalized name: long pepper extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long implants (11‐15 mm) with sinus grafting
Trial: 28081288
Drug: Short implants
RxNorm normalized name: short ragweed pollen extract Sublingual Tablet [Ragwitek]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short implants (6 mm) with sinus grafting
Trial: 23414585
Drug: Ganitumab (12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ganitumab (12 mg/kg bodyweight) + Fulvestrant (500 mg on day 1, then 250 mg on days 15, 29, and every 28 days)
Trial: 23414585
Drug: Ganitumab (12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ganitumab (12 mg/kg bodyweight) + Exemestane (25 mg once daily)
Trial: 23414585
Drug: Placebo +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo + Fulvestrant (500 mg on day 1, then 250 mg on days 15, 29, and every 28 days)
Trial: 23414585
Drug: Placebo +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo + Exemestane (25 mg once daily)
Trial: 23414585
Drug: Ganitumab (12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ganitumab (12 mg/kg bodyweight)
Trial: 19118617
Drug: Shi-Bi-Lin (SBL)
RxNorm normalized name: bis-ethoxydiglycol succinate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shi-Bi-Lin (SBL) capsules
Trial: 16500713
Drug: Amphetamine (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amphetamine (30 mg)
Trial: 14693608
Drug: Electric needle
RxNorm normalized name: NEEDLE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electric needle acupuncture over 15 min at analgesic points of the leg (n = 8)
Trial: 14693608
Drug: Sham treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham treatment (n = 8)
Trial: 11020090
Drug: Mindfulness meditation-based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mindfulness meditation-based stress reduction program (weekly meditation group lasting 1.5 hours for 7 weeks plus home meditation practice)
Trial: 9362436
Drug: Gallium nitrate
RxNorm normalized name: Gallium Nitrate
DrugBank: Gallium citrate (DB17893)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gallium nitrate (40 mg administered as a subcutaneous injection once daily for 2 weeks, followed by 2 weeks off treatment, recycled monthly)
Trial: 27619354
Drug: Multifaceted intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Multifaceted intervention including education, guideline development, elimination of recurring laboratory orders, unbundling of laboratory panels, redesign of the daily progress note.
Trial: 26276164
Drug: Local infiltration
RxNorm normalized name: Autologous tumor infiltrating lymphocytes
DrugBank: Lifileucel (DB17107)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local infiltration analgesia (LIA) - 150 ml ropivacaine 0.2 % with epinephrine intra‐operatively
Trial: 26276164
Drug: Interscalene brachial
RxNorm normalized name: Brachiara mutica pollen
DrugBank: Urochloa mutica pollen (DB10716)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interscalene brachial plexus catheter (ISC) - ropivacaine 0.75 %, 7 ml bolus followed by 48‐h 5 ml/h infusion
Trial: 21143256
Drug: Predefined pharmacist
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Predefined pharmacist intervention focusing on correct medication use, medication adherence, and healthy lifestyle promotion
Trial: 21143256
Drug: Predefined pharmacist
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Predefined pharmacist intervention with sustained pharmacotherapy changes
Trial: 15598919
Drug: Implantable cardioverter
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Implantable cardioverter defibrillator (ICD) or combined cardiac resynchronization therapy and defibrillator (CRT-D)
Trial: 15598919
Drug: All trials
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All trials combined (ICD therapy)
Trial: 10021718
Drug: 200 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg/kg porcine surfactant (Group A)
Trial: 10021718
Drug: 100 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg/kg porcine surfactant (Group B)
Trial: 10021718
Drug: 200 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg/kg porcine surfactant (Group A) in subgroup < 1500 grams
Trial: 10021718
Drug: 100 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg/kg porcine surfactant (Group B) in subgroup < 1500 grams
Trial: 8402378
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of IVD and traditional instruction
Trial: 3490270
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion of propofol during nitrous oxide anaesthesia
Trial: 25626738
Drug: Total intravenous
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total intravenous anaesthesia (TIVA) with propofol/remifentanil
Trial: 24337423
Drug: Interdisciplinary functional
RxNorm normalized name: plasma protein fraction Injection [Plasmanate]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interdisciplinary functional restoration treatment with cognitive behavior therapy
Trial: 16740371
Drug: MRgFUS without
RxNorm normalized name: threonine
DrugBank: Threonine (DB00156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: MRgFUS without pre-treatment
Trial: 9915271
Drug: 1.0 mmol/L
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 mmol/L dialysate calcium solution
Trial: 9915271
Drug: 1.25 mmol/L
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.25 mmol/L dialysate calcium solution
Trial: 8525396
Drug: Praziquantel (25mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Praziquantel (25mg/kg body weight in one dose)
Trial: 2305760
Drug: Successful transplantation
RxNorm normalized name: Washed Microbiota Transplantation
DrugBank: Washed Microbiota Transplantation (DB15745)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Successful transplantation (cyclosporine/prednisone therapy, N = 51)
Trial: 2305760
Drug: Successful transplantation
RxNorm normalized name: Washed Microbiota Transplantation
DrugBank: Washed Microbiota Transplantation (DB15745)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Successful transplantation (conventional immunosuppressive therapy; antilymphocyte globulin/prednisone/azathioprine, N = 40)
Trial: 7023415
Drug: Men's group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Men's group treatment for erectile dysfunction
Trial: 25317790
Drug: Ibuprofen 10
RxNorm normalized name: ibuprofen 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen 10 mg/kg, followed by 5 mg/kg after 24 and 48 hours
Trial: 22638934
Drug: Short-course radiotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short-course radiotherapy (SC-RT) 29 Gy in 10 twice daily fractions followed by immediate surgery; n=108
Trial: 22638934
Drug: Long-course radiochemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long-course radiochemotherapy (LC-RCHT) 54 Gy in 28 fractions with simultaneous 5-fluorouracil (5-FU) ± oxaliplatin chemotherapy followed by delayed surgery; n=117
Trial: 17084393
Drug: GnRH‐agonist/rFSH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GnRH‐agonist/rFSH
Trial: 17084393
Drug: GnRH‐antagonist/rFSH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GnRH‐antagonist/rFSH
Trial: 8207601
Drug: Intracordal injection
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intracordal injection therapy with atelocollagen (submucosal injection)
Trial: 8207601
Drug: Intracordal injection
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intracordal injection therapy with atelocollagen (intramuscular injection)
Trial: 2563321
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg pirbuterol thrice daily
Trial: 4607845
Drug: Ancrod therapy
RxNorm normalized name: ancrod
DrugBank: Ancrod (DB05099)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ancrod therapy
Trial: 29855660
Drug: 4-fluoroamphetamine (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4-fluoroamphetamine (100 mg)
Trial: 23391831
Drug: Scaling and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Scaling and root planing (SRP) plus 0.5% AZM gel
Trial: 19663110
Drug: Oligopeptide (Lumixyl)
RxNorm normalized name: oligopeptide 104
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oligopeptide (Lumixyl) 0.01% w/w, applied twice daily for 16 weeks
Trial: 14724157
Drug: Synbiotic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Synbiotic therapy (Lactobacillus acidophilus La5, Bifidobacterium lactis Bb‐12, Streptococcus thermophilus, Lactobacillus bulgaricus, and oligofructose)
Trial: 14724157
Drug: Placebo (placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (placebo capsules and sucrose powder)
Trial: 2549261
Drug: 4 g
RxNorm normalized name: CTX4 Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 g of ascorbic acid (vitamin C)/day plus 400 mg of alpha‐tocopherol (vitamin E)/day plus 22.5 g/day of grain fiber supplement
Trial: 2549261
Drug: 4 g
RxNorm normalized name: CTX4 Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 g of ascorbic acid (vitamin C)/day plus 400 mg of alpha‐tocopherol (vitamin E)/day alone
Trial: 24843060
Drug: 10 µg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 µg Engerix‐B
Trial: 24843060
Drug: 20 µg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 µg Engerix‐B
Trial: 24843060
Drug: Baseline (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baseline (no challenge dose)
Trial: 20146702
Drug: Omeprazole-Mg 20.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole-Mg 20.6 mg
Trial: 18434902
Drug: Hydrocortisone (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrocortisone (50 mg single bolus)
Trial: 18434902
Drug: Hydrocortisone (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrocortisone (50 mg every 6 hrs) plus Fludrocortisone (50 microg daily)
Trial: 10335903
Drug: Troglitazone 200
RxNorm normalized name: troglitazone 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Troglitazone 200 mg per day
Trial: 10335903
Drug: Troglitazone 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Troglitazone 600 mg per day
Trial: 2165888
Drug: Basal diet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basal diet with isocaloric addition of 1 g of meat protein day‐1 kg‐1
Trial: 26082974
Drug: Adjunct minocycline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjunct minocycline (100 mg oral capsule twice daily; n = 29)
Trial: 26082974
Drug: Adjunct minocycline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjunct minocycline
Trial: 21730224
Drug: 2 g/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 g/d of plant sterols (PS)
Trial: 19054288
Drug: Occlusal appliance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Occlusal appliance treatment
Trial: 16739842
Drug: Jingjin therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Jingjin therapy
Trial: 15589061
Drug: Allopurinol 100
RxNorm normalized name: allopurinol 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Allopurinol 100 mg three times a day for 14 days
Trial: 3544782
Drug: Thrombolytic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrombolytic treatment (streptokinase) for anterior AMI
Trial: 3544782
Drug: Thrombolytic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrombolytic treatment (streptokinase) for anterior AMI with Q waves
Trial: 3544782
Drug: Thrombolytic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrombolytic treatment (streptokinase) for anterior AMI with high ST elevation
Trial: 3544782
Drug: Thrombolytic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrombolytic treatment for inferior AMI